Rua Bioscience Archives | Page 2 of 5 | Cannabiz

We’re on a journey, says Rua chair, as capital raise falls short

by Steve Jones December 7, 2024April 11, 2025

Rua Bioscience has raised approximately NZ$1.2 million (A$1.1m) from investors as the company continued what chairwoman […]

Company news: Wellnex Life; Rua Bioscience; Althea

by Steve Jones and Martin Lane November 6, 2024April 11, 2025

Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue

by Steve Jones October 30, 2024October 30, 2024

News in brief: Drug-driving report; Rua Bioscience; Bod Science

by Steve Jones October 24, 2024February 25, 2025

Rua Bioscience under pressure to raise funds but looks to ‘positive future’

by Steve Jones October 10, 2024October 10, 2024

Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne

by Martin Lane and Steve Jones September 2, 2024September 3, 2024

Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira

by Steve Jones and Martin Lane August 28, 2024January 13, 2025

Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma

by Martin Lane and Steve Jones April 16, 2024July 16, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Cann Group vows to ‘vigorously’ defend Rua claims as contract dispute goes legal

by Steve Jones February 16, 2024November 25, 2024